No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The adoption of new technology in radiation oncology should rely on evidence-based medicine
1. K. J. Bozic, R. G. Pierce, and J. H. Herndon. “Health care technology assessment. Basic principles and clinical applications,” J. Bone Joint Surg. 86, 1305–1314 (2004).
2. D. L. Sackett et al. , “Evidence based medicine: What it is and what it isn’t,” Brit. Med. J. 312, 71–72 (1996).
3. E. Tanjong-Ghogomuy, P. Tugwell, and V. Welch, “Evidence-based medicine and the Cochrane Collaboration,” Bull. NYU Hosp. Joint Dis. 67, 198–205 (2009).
4. B. Fisher et al. , “Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer.” N. Engl. J. Med. 312, 665–673 (1985).
5. G. W. Stone et al. , “Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: The TAXUS V ISR randomized trial,” J. Am. Med. Assoc. 295, 1253–1263 (2006).
6. H. P. Soares et al. , “Evaluation of new treatments in radiation oncology: Are they better than standard treatments?,” J. Am. Med. Assoc. 293, 970–978 (2005).
10. U.S. Preventative Services Task Force, Guide to Clinical Preventive Services (Diane Publishing Co., Darby, PA, 1989).
13. S. M. Bentzen, “Towards evidence based radiation oncology: Improving the design, analysis, and reporting of clinical outcome studies in radiotherapy,” Radiother. Oncol. 46, 5–18(1998).
14. M. H. Ebell et al. , “Strength of recommendation taxonomy (SORT): A patient-centered approach to grading evidence in the medical literature,” Am. Fam. Physician, 69, 548–556 (2004).
15. J. L. Brozek et al. , “Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions,” Allergy 64, 669–677 (2009).
16. S. S. Dhruva, L. A. Bero, and R. F. Redberg, “Strength of study evidence examined by the FDA in premarket approval of cardiovascular devices,” J. Am. Med. Assoc. 302, 2679–2685 (2009).
18. B. Djulbegovic, “The paradox of equipoise: The principle that drives and limits therapeutic discoveries in clinical research,” Cancer Control 16, 342–347 (2009).
20. R. Jackson and G. Feder, “Guidelines for clinical guidelines,” Brit. Med. J. 317, 427–428 (1998).
Article metrics loading...
There is no abstract available for this article.
Full text loading...
Most read this month